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Background: Depression and cardiovascular diseases due to arteriosclerosis are both frequent and impairing
conditions. Depression and (subclinical) arteriosclerosis appear to be related in a bidirectional way, and it is
plausible to assume a partly joint causal relationship. However, the biological mechanisms and the behavioral
pathways that lead from depression to arteriosclerosis and vice versa remain to be exactly determined.
Methods/design: This study protocol describes the rationale and design of the prospective BiDirect Study that
aims at investigating the mutual relationship between depression and (subclinical) arteriosclerosis. BiDirect is
scheduled to follow-up three distinct cohorts of individuals ((i) patients with acute depression (N = 999), (ii) patients
after an acute cardiac event (N = 347), and (iii) reference subjects from the general population (N = 912)). Over the
course of 12 years, four personal examinations are planned to be conducted. The core examination program, which
will remain identical across follow-ups, comprises a personal interview (e.g. medical diagnoses, health care
utilization, lifestyle and risk behavior), a battery of self-administered questionnaires (e.g. depressive symptoms,
readiness to change health behavior, perceived health-related quality of life), sensory (e.g. olfaction, pain) and
neuropsychological (e.g. memory, executive functions, emotional processing, manual dexterity) assessments,
anthropometry, body impedance measurement, a clinical work-up regarding the vascular status (e.g. electrocardiogram,
blood pressure, intima media thickness), the taking of blood samples (serum and plasma, DNA), and structural and
functional resonance imaging of the brain (e.g. diffusion tensor imaging, resting-state, emotional faces processing).
The present report includes BiDirect-Baseline, the first data collection wave.
Discussion: Due to its prospective character, the integration of three distinct cohorts, the long follow-up time window,
the diligent diagnosis of depression taking depression subtypes into account, the consideration of relevant comorbidities
and risk factors, the assessment of indicators of (subclinical) arteriosclerosis in different vascular territories, and the
structural and functional brain imaging that is performed for a large number of participants, the BiDirect Study represents
an innovative approach that combines population-based cohorts with sophisticated clinical work-up methods and
that holds the potential to overcome many of the drawbacks characterizing earlier investigations.
Keywords: Depression, Depression subtypes, Arteriosclerosis, Cardiovascular, Cerebrovascular, (f)MRI,
White matter hyperintensities, Prospective cohort study, Bidirectional* Correspondence: h.teismann@uni-muenster.de
1Institute of Epidemiology and Social Medicine, University of Münster,
Münster, Germany
Full list of author information is available at the end of the article
© 2014 Teismann et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Teismann et al. BMC Psychiatry 2014, 14:174 Page 2 of 9
http://www.biomedcentral.com/1471-244X/14/174Background
Depression and cardiovascular diseases (CVD) are preva-
lent disorders in the general population. Both conditions
have a major impact on the affected individuals and, in
terms of quality of care and costs, on the health care sys-
tem [1]. Unipolar depressive disorders and ischemic heart
diseases are expected to become the two most common
causes of disability worldwide by 2030 [2].
Depression is a systemic and rather multifaceted and
heterogeneous illness. However, the term depression is
used for a variety of phenomena. Due to the non-
specificity of diagnostic categories (i.e. ICD-10, DSM-IV-
TR) and the response of depression to various treatment
modalities (i.e. medication, psychotherapy), the attempt
to form biologically meaningful subgroups of depressed
patients, so-called subtypes, has recently attracted con-
siderable attention [3]. The concept of depression sub-
types - i.e. atypical, melancholic, bipolar, or dysthymic
depression - postulates that each may relate to the risk
of developing CVD in a specific way [4].
CVDs, in turn, are a group of disorders of the heart
and blood vessels that include (amongst others) coron-
ary heart disease, cerebrovascular disease, and peripheral
arterial disease. According to the definition of the World
Health Organization, CVDs due to arteriosclerosis are
among the leading causes of morbidity and mortality in
Western countries. Arteriosclerosis is a complex sys-
temic condition that simultaneously affects large and
small arteries in different vascular territories. Arterio-
sclerotic lesions can develop early in life; however, the
disease usually progresses slowly and remains subclinical
until sudden clinical events such as myocardial infarc-
tion or stroke occur [5,6]. The presence of lesions in the
white matter of the brain (so-called white matter hyper-
intensities), which can be detected with brain imaging
methods such as magnetic resonance imaging (MRI),
can be an indicator of cerebral arteriosclerosis [7]. Al-
though not routinely considered, measurements of
(subclinical) arteriosclerosis appear particularly suited to
study the association between depression and CVD: in
contrast to counting clinical events like myocardial in-
farction or stroke, the degree of arteriosclerosis is a con-
tinuous outcome variable that can be operationalized via
several different measures, and that can be collected for
every study participant with comparatively little effort
and burden.
Arteriosclerosis and depression appear to be related,
and the current literature suggests that this relationship
is bidirectional [1]. First, depression has shown to be
both a robust and significant risk and prognostic marker
for CVD incidence [8] and an independent predictor of
poorer CVD outcome [4,9,10]. Next, a considerable pro-
portion of CVD patients develop depression, leading
to significantly increased morbidity and mortality [11].Finally, patients suffering from both CVD and depres-
sion at the same time have a significantly increased risk
for future cardiac events compared to CVD patients
without depression [4].
Given the apparent association between depression
and CVD, it appears plausible to assume a partly joint
causal relationship. Studies addressing this issue have
mainly focused on potentially shared biological mecha-
nisms. They found that the autonomic nervous system,
platelet receptors and function, coagulation factors (e.g.
fibrinogen, PAI-1), pro-inflammatory cytokines, endo-
thelial function as well as hormonal and genetic pro-
cesses may be involved [1,4,12]. In addition to shared
biological determinants, there are behavioral and cogni-
tive pathways that may lead from depression to CVD
and vice versa. Thus, specific behavioral and/or lifestyle
factors that are frequently observed in patients with de-
pression (e.g. smoking, obesity, inactivity, poor diet, poor
treatment adherence) may modify the risk to develop
subsequent CVD [13,14]. In particular, physical inactivity
seems to play an important role [15,16]. Crucially, there
is evidence indicating that patients suffering from certain
subtypes of depression (e.g. patients with atypical de-
pression) are prone to show such maladaptive behavior,
emphasizing the need to establish a classification of de-
pression that takes different subtypes into account. In
addition, it appears reasonable to consider known and
prognostically important clinical characteristics of de-
pression, such as the number of depressive episodes,
symptom severity, or age at first onset and disease dur-
ation. These factors have received little attention in the
published literature so far. Patients with CVD may per-
ceive themselves as being confronted with actual or
imminent burdens (e.g. heart symptoms, changes in cog-
nitive functioning) and losses (e.g. reduced quality of life,
decrease in independence or functional capacity), which
could contribute to the increased risk of developing
subsequent depression. Again, it appears worthwhile to
focus closely on the actual manifestation of depression,
as certain subtypes or features may appear more fre-
quently than others. Certain demographic factors such
as age, gender, socio-economic status, or psychosocial
factors (e.g. personality, social integration, adverse life
events) and comorbidities such as history of depression,
anxiety, or childhood trauma might modify the risk to
develop either depression, CVD, or one of the two dis-
eases subsequent to the other one.
Noteworthy, due to methodological aspects of previ-
ous studies, there is an ongoing debate as to whether de-
pression can be safely considered as an independent risk
factor for CVD. Among the shortcomings were cross-
sectional designs, short follow-up periods, exclusive reli-
ance on depression scores for the classification of
depression, non-accountancy of somatic comorbidities
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tion of the interaction between age and gender and de-
pression and CVD, and delayed retrospective inquiry of
depressive symptoms potentially preceding the cardiac
event [17].
In the present article, we describe the goals and design
of the BiDirect Study [18], which investigates the mutual
relationship between depression and (subclinical) ar-
teriosclerosis. Due to the prospective character of the
study, the integration of three distinct cohorts (i.e. pa-
tients with depression, patients with CVD, and reference
subjects from the same general population), the sched-
uled follow-up time window of 12 years, the diligent
diagnosis of depression, the assessment of relevant co-
morbidities and risk factors, and the focus on potential
age and gender effects, BiDirect holds the potential to
overcome many of the drawbacks characterizing earlier
investigations.
This report includes the first data collection wave
(BiDirect-Baseline), which was conducted from July 2010
to June 2013. The BiDirect Study is scheduled to end after




The primary objectives of BiDirect are to investigate (i)
whether depression contributes to the onset and severity of
(subclinical) arteriosclerosis, and (ii) whether the severity of
(subclinical) arteriosclerosis is related to incident depression.
The focus will be on the course of depression, depression
subtypes, lifestyle-related behavioral risk factors, and gender.
In detail, the following hypotheses will be evaluated: (1) Pa-
tients with depression have more (subclinical) arterioscler-
osis than non-depressed individuals of the same age and
gender. The severity of (subclinical) arteriosclerosis is related
to the prior course of depression and differs between sub-
types. (2) Patients with depression show a more unfavorable
lifestyle compared to non-depressed individuals. (3) Patients
with CVD are at increased risk to develop depression com-
pared to individuals without CVD and present with different
subtypes of depression rather than merely adjustment dis-
order with depressed mood. (4) Patients with both CVD and
depression show a more unfavorable lifestyle and present
with prevailing physical symptoms of depression compared
to patients with solely CVD. (5) Gender modifies the rela-
tionship between depression and (subclinical) arterioscler-
osis. (6) The severity of (subclinical) arteriosclerosis and the
subtype of depression allow describing pathophysiological
pathways that are shared by both diseases.
Study design
BiDirect is a prospective observational study that inte-
grates three different cohorts. In addition to BiDirect-Baseline, three follow-up examinations are scheduled to
be conducted over the course of 12 years. While the
core examination program will remain unchanged across
follow-ups, modifications (i.e. expansions and reduc-
tions) due to changing demands are allowed for. A short
questionnaire is mailed to all participants one year after
each of these examinations. This questionnaire covers
the perceived health state (and recent changes thereof ),
recent medical diagnoses, work and living situation, new
life events, perceived depressive symptoms, and current
medication.Recruitment of participants
The study was approved by the ethics committee of the
University of Münster and the Westphalian Chamber of
Physicians in Münster, North-Rhine-Westphalia, Germany.
Written informed consent for participation in the study
was obtained from all participants. Overall, 2315 partici-
pants were recruited for BiDirect-Baseline; 2258 (97.5%) of
them matched the final inclusion criteria. Basic demo-
graphic characteristics of the three cohorts are summarized
in Table 1.
Cohort 1 consisted of 999 patients, who suffered from
an episode of depression at the time of recruitment. Re-
cruitment took place at six different psychiatric and psy-
chosomatic hospitals and departments located in and
around the city of Münster (radius: 35 km), as well as
two resident psychiatrists’ practices located in Münster.
The recruitment of outpatients was limited to those who
had been hospitalized due to depression at least once
during the 12 months period prior to inclusion into the
study. Inclusion criteria were (i) age (≥35 and < 66 years)
and (ii) current in- or outpatient treatment due to acute
depression. Exclusion criteria were (i) compulsory ad-
mission, (ii) comorbid dementia, and (iii) comorbid drug
abuse (including alcohol). Potential participants were
ascertained by trained and certified study psychologists,
and eligible patients were invited to participate in
BiDirect-Baseline. Appointments were scheduled via
telephone or email.
Cohort 2 comprised 347 patients with CVD (excluding
cerebrovascular disease) who were recruited by trained
and certified study nurses in four different cardiology
departments and rehabilitation clinics in and around
Münster (radius: 50 km). Inclusion criteria were (i) age
(≥35 and < 66 years) and (ii) acute myocardial infarction,
or acute coronary syndrome requiring therapy, or treat-
ment of cardiac disease due to myocardial infarction
within the last three months. In case of consent, the
CVD patients were invited to participate in BiDirect-
Baseline two months after recruitment by the study
nurse, and appointments were scheduled via telephone
or email.
Table 1 Basic demographic characteristics (absolute and relative frequencies) of the BiDirect-Baseline participants
stratified by cohort
Cohort
Variable Depression (N = 999) CVD (N = 347) Reference (N = 912)
Sex
Female 593 (59.4%) 49 (14.1%) 464 (50.9%)
Male 406 (40.6%) 298 (85.9%) 448 (49.1%)
Age
35 to 44 years 285 (28.5%) 29 (8.4%) 194 (21.3%)
45 to 54 years 437 (43.7%) 128 (36.9%) 304 (33.3%)
55 to 65 years 277 (27.7%) 190 (54.8%) 414 (45.4%)
Educational level
University degree 238 (23.8%) 99 (28.5%) 375 (41.1%)
University entrance diploma or vocation diploma 181 (18.1%) 56 (16.1%) 157 (17.2%)
General certificate of secondary education 278 (27.8%) 86 (24.8%) 187 (20.5%)
Certificate of secondary education or lower 295 (29.5%) 104 (30.0%) 189 (20.7%)
Net household income1 per month
≤ 2000 Euro 345 (34.5%) 56 (16.1%) 182 (20.0%)
> 2000 Euro 651 (65.2%) 290 (83.6%) 726 (79.6%)
1Sum across all household members after tax and social charges.
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dwelling adults (age: ≥ 35 and < 66 years). The partici-
pants had been randomly sampled from the population
register of the city of Münster and were invited for
BiDirect-Baseline via letter; appointments were sched-
uled by telephone or email.
Baseline response rates for the depression and CVD
cohorts could not be estimated. In both cases, recruit-
ment took place on site, and potential participants could
be addressed by several different physicians or members
of the nursing staff; therefore, the basic populations of
those who were asked to participate are not known. The
baseline response rate in the reference cohort was
41.5%.
Diagnosis of depression
The thorough assessment of depressive symptoms is a
key concern of BiDirect-Baseline and a prerequisite for
the testing of the specific BiDirect hypotheses over the
course of the study. During BiDirect-Baseline, different
measures were combined in order to confirm psychiatric
diagnoses and to determine whether a participant suf-
fered from acute depression with melancholic or atypical
features. For patients from cohort 1, assessment of de-
pression was conducted during recruitment. For partici-
pants from cohorts 2 and 3, (when necessary) diagnosis
of depression took place during the BiDirect-Baseline
examination at the study center.
For diagnostic purposes, all participants received se-
lected modules (i.e. modules A, A’, B, D, and O) of theM.I.N.I. International Neuropsychiatric Interview (German
version 5.0.0) [19], which assessed whether a participant
exhibited acute (first or recurrent) major depression with
or without melancholic features, acute dysthymia, acute/
former manic/hypomanic episodes, or acute generalized
anxiety disorder. Further, for all patients from cohort 1 and
for those participants from cohorts 2 and 3 who had re-
ceived a M.I.N.I. diagnosis of acute major depression, it
was clarified whether atypical depression features were cur-
rently present by means of six selected items of the Inven-
tory of Depressive Symptomatology (IDS) [20] (items 8, 12,
14, 27, 29, and 30). In addition, all patients with depres-
sion were assessed using the 17 items version of the
Hamilton Depression Rating Scale (HAM-D-17) [21]
and the 14 items version of the Hamilton Anxiety
Rating Scale (HAM-A-14) [22]. It was also assessed
whether a participant ever had episodes of melancholic
or atypical depression throughout lifetime. Eventually,
for explorative purposes we formed so-called “probable”
subtypes: if a participant showed all but one criterion
for melancholic or atypical depression, the diagnoses
“probable melancholic depression” or “probable atypical
depression” were assigned.
Notably, in some cases melancholic and atypical fea-
tures of depression were present at the same time (sub-
type mixed). In other cases, an assignment to one of the
categories melancholic depression or atypical depression
was not possible (subtype undifferentiated). Table 2
summarizes the frequencies of the different depression
subtypes in cohort 1.
Table 2 Absolute and relative frequencies of depression
subtypes among N = 9201 individuals from the
depression cohort




Probably melancholic 27 (2.9%)
Probably atypical 39 (4.2%)
Probably mixed 68 (7.4%)
Melancholic + probably melancholic 581 (63.2%)
Atypical + probably atypical 83 (9.0%)
Mixed + probably mixed 163 (17.7%)
Undifferentiated 93 (10.1%)
1Number of members of the depression cohort (N = 999) for whom the
subtype diagnostic algorithm could be successfully completed.
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Selection bias was reduced by cooperation with the hos-
pitals providing in- or outpatient treatment for psychi-
atric and cardiologic diseases to the population of the
city of Münster. Thus, newly occurring cases of depres-
sion, myocardial infarction, and acute coronary syndrome
requiring in-hospital treatment in the participating institu-
tions during the critical period fulfilling inclusion criteria
and willing to participate could be recruited. The incorp-
oration of a population-based reference cohort is a
prerequisite for the analysis of the association between de-
pression and (subclinical) arteriosclerosis in a truly bidir-
ectional way. The reference subjects were randomly
sampled from the population (i.e. inhabitants of the city of
Münster) that gave rise to the depression and CVD
cohorts. Moreover, we assessed the majority of variables
known to be potential confounders of the association
between depression and CVD. Among them are socio-
demographic factors, existing comorbidities, lifestyle fac-
tors, and current medications. The assessment of these
variables allows to control their effects in the applied stat-
istical models and to evaluate their roles as either con-
founders or mediators.Data collection procedures
The large majority of the data for BiDirect-Baseline
(with the exception of the psychiatric interviews, which
were administered by trained and certified study psy-
chologists in most cases at the hospitals where recruit-
ment took place) was collected by trained and certified
study nurses at the BiDirect study center, which is an in-
tegral part of the Institute for Epidemiology and Social
Medicine, University of Münster, Germany. The MRI
scans were obtained by the staff of the Department for
Clinical Radiology, University of Münster.Constructs and instruments
The BiDirect-Baseline examination included several dif-
ferent modules: (i) computer assisted personal interview
(CAPI), (ii) psychiatric interview (where required), (iii)
self-administered questionnaires, (iv) assessment of sen-
sory/cognitive functioning, and (v) diagnostic work-up
(including MRI of the brain and taking of blood sam-
ples). Completing the entire program required an aver-
age of three-and-a-half hours.
By means of the CAPI, which was applied in German lan-
guage, detailed information regarding socio-demographic
and socio-economic background, lifetime medical diagno-
ses, health care utilization behavior, insurance status, life-
style and risk behavior (i.e. diet, physical activity, alcohol
consumption, smoking), and current medication was ob-
tained, for the most part using standardized sets of closed
questions which had previously been used in different stud-
ies [23,24]. In addition, there were sections devoted to per-
ceived health state. In case of female participants, the
number of children, oral contraceptive usage, and certain
surgical interventions (i.e. hysterectomy, ovariectomy) were
inquired. Notably, for the participants of cohorts 2 and 3,
the diagnostic M.I.N.I. interview was included in the CAPI.
If indicated by the M.I.N.I. results, an additional appoint-
ment was scheduled, where additional non-structured and
structured (HAM-D-17, HAM-A-14, selected IDS items)
psychiatric interviews were administered by trained and
certified study psychologists. The goal of these interviews
was to assess the severity of depression and anxiety symp-
toms, and to evaluate whether or not a participant suffered
from melancholic or atypical depression. For patients from
cohort 1, the diagnostic and psychiatric interviews had
already been conducted during recruitment (cf. section
“Diagnosis of depression”).
Several different self-administered questionnaires or
sets of questions, which were combined to form a single
booklet, were completed by the participants. The follow-
ing instruments/sets were used in given order: (i) the
Pittsburgh Sleep Quality Index (PSQI) [25], which as-
sesses sleep quality and disturbances over a one-month
time interval; (ii) the Center for Epidemiological Studies
Depression Scale (CES-D) [26], which was designed to
measure depressive symptomatology over a one-week
time interval; (iii) a headache questionnaire [27]; (iv) the
Pain Sensitivity Questionnaire (PSQ) [28], a measure of
pain perception based on imagined painful daily life situ-
ations; (v) a set of six questions regarding perceived
memory functioning and recent changes thereof; (vi) the
Childhood Trauma Screener (CTS) [29], which covers
general living conditions and traumata during childhood
(performed in a subsample of the baseline participants); (vii)
a set of seven questions assessing the readiness to change
health behavior (i.e. physical activity, diet, weight, alcohol
consumption, smoking) according to the transtheoretical
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perceived health-related quality of life.
In order to test sensory functioning, an orienting as-
sessment of color perception was performed using 14
Ishihara Color Plates. Further, visual acuity was assessed
(left vs. right eye). Moreover, odor perception was
examined using the Sniffin’ Sticks Screening 12 Test
(Burghart Messtechnik GmbH, Wedel, Germany), a
forced choice test which allows categorizing participants
into anosmic, hyposmic, and normosmic based on 12
different odors. Further, the pressure pain threshold
was determined using a pain test algometer (Force Dial
FDK/FDN Force Gage, Wagner Instruments, Greenwich,
CT, USA) for left and right index fingers separately.
The cognitive functioning module included the assess-
ment of cognitive processing speed, verbal working and
long-term memory, executive functions (verbal fluency,
interference disposition, flexibility), emotional process-
ing, and manual dexterity. The following tests were
administered in given order: (i) immediate recall of a se-
quence of 12 (recorded and replayed) spoken German
nouns, each with an emotional load (positive, neutral, or
negative) (cf. [32]); (ii) verbal production of as many dif-
ferent animal names as possible within a time interval of
one minute [33]; (iii) Color-Word-Interference Test [34];
(iv) Trail Making Tests A and B [35]; (v) delayed recall
of the nouns (see above); (vi) rating of the nouns regard-
ing valence and arousal on nine-point rating scales; and
(vii) Purdue Pegboard Test [36] for left and right hands
separately. Eventually, the participants self-evaluated
their level of attention during the cognitive functioning
module on an eleven-point rating scale.
The diagnostic work-up began with the determination
of weight (without shoes and heavier clothes), height,
and waist circumference. Bioelectrical impedance meas-
urement (Body Impedance Analyzer BIA 2000-S, Data
Input GmbH) including the determination of body fat
and water, extracellular mass, body cell mass, and basic
metabolic rate was applied. The determination of the
vascular status consisted of the measurement of a stand-
ard 3-channel electrocardiogram (ECG) using extremity
leads, the brachial systolic and diastolic blood pressure
by oscillometry, the ankle-brachial index by photo-
plethysmography, the pulse wave velocity, the augmenta-
tion index (Vascular Explorer, enverdis GmbH), and the
intima-media-thickness of the far wall of the carotid
arteries non-invasively by ultrasound (Acuson X300,
Siemens). In addition, blood samples were taken
(plasma, serum, and DNA), and fundus photography
(Digital Retinography System, EyeNovation) was per-
formed in a subsample of the baseline participants. The
diagnostic-workup closed with an MRI of the brain,
which involved both structural (3D-T1, T2*, FLAIR, and
DTI sequences) and functional (resting-state sequence,emotional faces paradigm [37]) recordings. Table 3 gives
an overview regarding the number of completed exami-
nations per cohort.
Quality assurance and data management
The primary goal of all quality assurance measures was
to generate high quality data. In principle, we followed
the rules for good epidemiological practice as well as
the recommendations for the use and storage of blood
samples and DNA as provided by the German Society
of Epidemiology (cf. http://dgepi.de/fileadmin/pdf/leitli-
nien/GEP_LL_english_f.pdf). The storage of biomaterials
was split between different refrigerators, all of which were
monitored by a central alert system 24 hours per day
seven days per week. The BiDirect standard operations
manual contains operating procedures for all BiDirect
interview and examination components.
Prior to the beginning of BiDirect-Baseline, the mem-
bers of the study team (i.e. study nurses, study psycholo-
gists) underwent an initial three-months training ending
with certifications. Moreover, each member of the study
staff was trained and certified for a variety of tasks, pro-
viding mutual backup in case of illness or changes in
personnel. Performance was closely monitored and rou-
tinely assessed.
Data management has been carried out in parallel with
data collection, based on standardized and partly auto-
mated procedures for data processing and plausibility
checking. Data backup routines are scheduled on a daily
basis.
Biometric concept and statistical analyses
The primary endpoints of BiDirect are incidence and/or
progression of both depressive symptoms and (subclin-
ical) arteriosclerosis. Secondary endpoints are onset of
depression, myocardial infarction, brain infarction, and
death. Current data evaluation is restricted to the base-
line cross-sectional analyses, since the first follow-up
period is still ongoing. Depending on the outcome scale
level (continuous vs. categorical) and time point of as-
sessment (baseline vs. follow-up), the statistical methods
comprise multivariable linear or logistic regression ana-
lyses, accounting for time-varying predictors and re-
peated outcome assessment.
The primary endpoints are operationalized by closed
questions and non-invasive clinical examinations. The
majority of primary endpoints yield continuous variables
(e.g. CES-D summary score, systolic/diastolic blood
pressure [mmHg], intima media thickness [mm]) with
change over time. The computation of arteriosclerosis
scores will facilitate the analysis of disease progression
in different vascular territories. Power calculations were
based on the planned study duration of 12 years and
took secondary, frequency-type endpoints (in particular
Table 3 Absolute and relative frequencies of examinations completed1 by the BiDirect-Baseline participants stratified
by cohort
Cohort
Examination Depression (N = 999) CVD (N = 347) Reference (N = 912)
Computer-assisted personal interview 996 (99.7%) 346 (99.7%) 911 (99.9%)
Sensory functioning
Pain 953 (95.4%) 304 (87.6%) 795 (87.2%)
Olfaction 989 (99.0%) 341 (98.3%) 901 (98.8%)
Visual acuity 996 (99.7%) 344 (99.1%) 907 (99.5%)
Cognitive functioning 964 (95.5%) 332 (95.7%) 824 (90.4%)
Anthropometry 998 (99.9%) 347 (100.0%) 890 (97.6%)
Body impedance 984 (98.5%) 331 (95.4%) 896 (98.2%)
Vascular status
Electrocardiogram 988 (98.9%) 345 (99.4%) 905 (99.2%)
Blood pressure 987 (98.8%) 340 (98.0%) 902 (98.9%)
Intima media thickness 987 (98.8%) 345 (99.4%) 894 (98.0%)
Blood sample
DNA 929 (93.0%) 321 (92.5%) 783 (85.9%)
Serum and plasma 895 (89.6%) 302 (87.0%) 742 (81.4%)
MRI
Anatomical 735 (73.6%) 52 (15.0%) 669 (73.4%)
Resting state 719 (72.0%) 51 (14.7%) 654 (71.7%)
Emotional faces 621 (62.2%) 43 (12.4%) 528 (57.9%)
1No refusal by participant or abortion by participant/examiner.
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factor) into account. Loss-to-follow-up between subse-
quent examinations was expected to be maximally 20%
on average across cohorts.
Discussion
BiDirect-Baseline, the first data collection wave of the
longitudinal BiDirect Study, has been successfully com-
pleted, and forms the foundation for investigating the
bidirectional relationship between depression and (sub-
clinical) arteriosclerosis prospectively.
The burden of depression and CVD on the health care
system is continuously growing. Therefore, it is signifi-
cant to state that a number of aspects of BiDirect are in-
novative and can be expected to generate knowledge
regarding the underlying biological (i.e. inflammatory,
hormonal) and behavioral (i.e. lifestyle-related) mecha-
nisms that may lead to more specific and more effective
treatment strategies in the future.
First and foremost, BiDirect takes a distinguished view
on depression. While many previous studies investiga-
ting the relationship between depression and CVD
adopted a non-differential, single-diagnostic-entity con-
cept of depression, BiDirect will explicitly discriminate
between different subtypes. The magnitude of the associ-
ation between depression and CVD appears to vary bydepression subtype, and thus it is possible that subtype-
specific biological mechanisms exist that link the two
conditions. A literature review of our group [12] came
to the conclusion that there are indications for subtype-
specific associations with regard to at least immune
activation and hypothalamic-pituitary-adrenal axis hyper-
activity. However, so far there are no prospective studies
addressing this issue, and BiDirect will be in the first line
to closing this gap. There are different ways to classify
patients with depression, among them etiology-based,
treatment-based, time-of-onset-based, and gender-based
approaches [3]. The most established way is to form sub-
types due to prevalent constellations of symptoms. Our
present classification based on M.I.N.I. and IDS results is
one such example. However, we plan to apply further,
more data-driven strategies to differentiate patients with
different forms of depression. For instance, it may be pos-
sible to classify patients based on the available biologic
and genetic markers.
Secondly, BiDirect includes the assessment of indica-
tors of (subclinical) arteriosclerosis in different vascular
territories. This enables, in addition to event-type
endpoints of clinical manifestation (i.e. myocardial in-
farction, stroke, death), the assessment of further
(continuous) outcomes (e.g. ankle-brachial blood pres-
sure index, pulse-wave velocity, intima-media-thickness).
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similar to the discrimination between depression sub-
types, is expected to contribute to a better understan-
ding of the biological and behavioral mechanisms
underlying the depression – CVD relationship. Further,
combinations of vascular parameters over different vascu-
lar territories, e.g. in the form of arteriosclerosis scores,
may help to better elucidate the subclinical arteriosclerotic
burden and, in particular, its change over time.
Finally, structural and functional brain imaging is
performed for a large number of participants. The
structural MRI data display (pathological) anatomical
changes, which can be quantified, for instance, by means
of voxel-based morphometry. Of primary interest in
BiDirect are so-called white-matter hyperintensities,
which are considered to be potential precursors of e.g.
stroke and vascular depression [38-40]. The functional
MRI data allow analyses of both the activation and con-
nectivity of brain regions. Using a facial expression pro-
cessing task [37], the activation of the cortico-limbic
circuitry involved in emotion processing and regulation
can be studied. Of particular interest in BiDirect are
amygdala, dorsolateral prefrontal cortex, dorsal anterior
cingulate cortex, and lateral orbitofrontal cortex. The task-
free resting-state fMRI sequence allows the evaluation of
functional connectivity of distant brain regions and thus
of the integrity of large-scale brain networks [41].
In conclusion, the BiDirect Study represents an in-
novative approach, combining population-based cohorts
with sophisticated clinical work-up methods. The BiDir-
ect team welcomes collaborations with both internal and
external researchers.
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